BRPI0520049A2 - composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma - Google Patents

composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma

Info

Publication number
BRPI0520049A2
BRPI0520049A2 BRPI0520049-0A BRPI0520049A BRPI0520049A2 BR PI0520049 A2 BRPI0520049 A2 BR PI0520049A2 BR PI0520049 A BRPI0520049 A BR PI0520049A BR PI0520049 A2 BRPI0520049 A2 BR PI0520049A2
Authority
BR
Brazil
Prior art keywords
osteoblast
fibrin
semi
bone
solid
Prior art date
Application number
BRPI0520049-0A
Other languages
English (en)
Inventor
Hyun-Shin Park
Jae-Deog Jang
Cheong-Ho Chang
Soo-Jin Jung
Sae-Bom Lee
Chang-Kwon Ko
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of BRPI0520049A2 publication Critical patent/BRPI0520049A2/pt
Publication of BRPI0520049B1 publication Critical patent/BRPI0520049B1/pt
Publication of BRPI0520049B8 publication Critical patent/BRPI0520049B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)

Abstract

COMPOSIçãO SEMI-SóLIDA DE OSTEOBLASTOS CONTENDO FIBRINA PARA A UNIãO OSSEA E MéTODO PARA O PREPARO DA MESMA. Cujo método compreende o isolamento dos osteoblastos de um tecido ósseo e o cultivo/proliferação dos osteoblastos isolados, no meio de cultura DMEM (Dulbecco's Modified Eagle's Medium) ou ci - MEM (Minimum Essential Medium, Alpha Modification), para o preparo de uma suspensão de osteoblastos, e a mistura da suspensão de osteoblastos resultantes com um fator de coagulação, para o preparo de um agente terapêutico de osteoblastos. De acordo com a presente invenção, cuja construção é feita de acordo com a descrição acima mencionada, é possível realizar o enxerto ósseo e, consequentemente, a união óssea, sem apresentar nenhuma rejeição clínica ao enxerto, com distribuição uniforme dos osteoblastos, através da injeção de uma mistura constituída de osteoblastos e fibrina, nas partes afetadas, para a união óssea, sendo que a união óssea é obtida de forma rápida e eficaz, através da injeção constante de uma composição semi-sólida de osteoblastos, nas partes afetadas.
BRPI0520049A 2005-06-13 2005-08-03 composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma BRPI0520049B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020050050450A KR100702250B1 (ko) 2005-06-13 2005-06-13 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법
KR102005-0050450 2005-06-13
PCT/KR2005/002531 WO2006135126A1 (en) 2005-06-13 2005-08-03 Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method

Publications (3)

Publication Number Publication Date
BRPI0520049A2 true BRPI0520049A2 (pt) 2009-04-14
BRPI0520049B1 BRPI0520049B1 (pt) 2020-12-22
BRPI0520049B8 BRPI0520049B8 (pt) 2021-05-25

Family

ID=37532459

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520049A BRPI0520049B8 (pt) 2005-06-13 2005-08-03 composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma

Country Status (19)

Country Link
US (1) US20080213229A1 (pt)
EP (1) EP1890713B1 (pt)
JP (1) JP2008532723A (pt)
KR (1) KR100702250B1 (pt)
CN (1) CN101247814A (pt)
AT (1) ATE503486T1 (pt)
BR (1) BRPI0520049B8 (pt)
CY (1) CY1111795T1 (pt)
DE (1) DE602005027260D1 (pt)
DK (1) DK1890713T3 (pt)
ES (1) ES2362430T3 (pt)
HR (1) HRP20110391T1 (pt)
MX (1) MX2007012041A (pt)
PL (1) PL1890713T3 (pt)
PT (1) PT1890713E (pt)
RS (1) RS51724B (pt)
SG (1) SG162750A1 (pt)
SI (1) SI1890713T1 (pt)
WO (1) WO2006135126A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101037002B1 (ko) * 2008-09-30 2011-05-25 세원셀론텍(주) 연골세포 조기배양을 위한 연골세포 특이적 배양방법
KR100932945B1 (ko) 2009-01-16 2009-12-21 원광대학교산학협력단 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드
KR100932948B1 (ko) * 2009-01-16 2009-12-21 원광대학교산학협력단 Ｂｍｐ-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드
WO2020161747A1 (en) * 2019-02-08 2020-08-13 Regrow Biosciences Private Limited Osteoblast cell-mixture, and implementations thereof
CN113827778B (zh) * 2021-11-03 2022-10-21 浙江赛灵特医药科技有限公司 一种注射式骨修复剂及其应用
CN113975468A (zh) * 2021-11-11 2022-01-28 成都中科娥皇健康咨询有限公司 一种骨膜组织老化修复剂及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US6599515B1 (en) * 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
DE19949290A1 (de) * 1999-10-12 2001-04-26 Albrecht Bettermann Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
CN1426290A (zh) * 2000-03-03 2003-06-25 史密夫和内修有限公司 用于骨缺陷的定形颗粒和组合物以及该颗粒的制作方法
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
KR100522457B1 (ko) * 2002-04-13 2005-10-18 주식회사 셀론텍 뼈세포의 배양방법 및 조성물
EP1635887A2 (en) * 2003-06-12 2006-03-22 Interface Biotech A/S A method for cell implantation
US7316822B2 (en) * 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery

Also Published As

Publication number Publication date
BRPI0520049B1 (pt) 2020-12-22
SI1890713T1 (sl) 2011-07-29
DK1890713T3 (da) 2011-06-27
EP1890713A4 (en) 2009-07-08
EP1890713B1 (en) 2011-03-30
DE602005027260D1 (de) 2011-05-12
PL1890713T3 (pl) 2011-09-30
KR20060129795A (ko) 2006-12-18
JP2008532723A (ja) 2008-08-21
WO2006135126A1 (en) 2006-12-21
ATE503486T1 (de) 2011-04-15
ES2362430T3 (es) 2011-07-05
HRP20110391T1 (hr) 2011-06-30
MX2007012041A (es) 2008-03-10
KR100702250B1 (ko) 2007-04-03
EP1890713A1 (en) 2008-02-27
CY1111795T1 (el) 2015-10-07
SG162750A1 (en) 2010-07-29
US20080213229A1 (en) 2008-09-04
CN101247814A (zh) 2008-08-20
PT1890713E (pt) 2011-06-09
BRPI0520049B8 (pt) 2021-05-25
RS51724B (sr) 2011-10-31

Similar Documents

Publication Publication Date Title
Fennema et al. Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study
Nourissat et al. Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model
Wilson et al. Adipose-derived mesenchymal stem cells enhance healing of mandibular defects in the ramus of swine
Orsi et al. A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats
Chai et al. Injectable photo-crosslinked bioactive BMSCs-BMP2-GelMA scaffolds for bone defect repair
Beigi et al. Activated platelet‐rich plasma improves cartilage regeneration using adipose stem cells encapsulated in a 3D alginate scaffold
CY1111795T1 (el) Συνθεση οστεοβλαστη ημιστερεοποιημενης αναμεμιγμενης φιμπρινης για συγκολληση καταγματος οστου και η μεθοδος παρασκευης αυτης
Wei et al. Effect of mesenchymal stem cells and platelet‐rich plasma on the bone healing of ovariectomized rats
Wang et al. Hydrogel fibers encapsulating human stem cells in an injectable calcium phosphate scaffold for bone tissue engineering
El‐Jawhari et al. Collagen‐containing scaffolds enhance attachment and proliferation of non‐cultured bone marrow multipotential stromal cells
Neubauer et al. The Effect of Blood‐Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose‐Derived Mesenchymal Stem Cells Originated from Three Different Locations
Sivan et al. Matrix‐directed differentiation of human adipose‐derived mesenchymal stem cells to dermal‐like fibroblasts that produce extracellular matrix
Montes-Medina et al. Effect of bone marrow stromal cells in combination with biomaterials in early phases of distraction osteogenesis: An experimental study in a rabbit femur model
Zou et al. Phenotypic, trophic, and regenerative properties of mesenchymal stem cells from different osseous tissues
Xie et al. Effects of PRP and LyPRP on osteogenic differentiation of MSCs
Pitkänen et al. Characterisation and in vitro and in vivo evaluation of supercritical-CO2-foamed B-TCP/PLCL composites for bone applications
Pagani et al. Update on synthetic biomaterials combined with fibrin derivatives for regenerative medicine: Applications in bone defect treatment: Systematic review
Chen et al. Synergetic effects of hBMSCs and hPCs in osteogenic differentiation and their capacity in the repair of critical-sized femoral condyle defects
Zhong et al. In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma
Kossev et al. Platelet-rich plasma (PRP) in orthopedics and traumatology—review
Shevchenko et al. The effect of osteosubstitution by platelet-rich autofibrin and hydroxyapatite ceramic with ß-tricalcium phosphate on biochemical parameters of blood in rabbits
MY136958A (en) Semi-solid osteoblast composition containing fibrin for bone union and method preparing the same
WO2022092169A1 (ja) 骨形成組成物およびその用途
Dahr et al. Platelet-rich plasma enhances the cellular function of equine bone marrow-derived mesenchymal stem cells
KR20130133612A (ko) ＰＲＰ(Ｐｌａｔｅｌｅｔ－Ｒｉｃｈ Ｐｌａｓｍａ)를 유효성분으로 포함하는 세포 부착능 및 귀소능 증진용 조성물

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/08/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2681 DE 24-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.